Clinical Trial Update: Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382 [Phase 1]

View source ↗

Summary

A Phase 1 study in patients with chronic hepatitis C infection evaluating safety, tolerability, pharmacokinetics and antiviral activity of JNJ-47910382; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• JNJ-47910382

Snippet

Sponsor: Janssen R&D Ireland | Conditions: Chronic Hepatitis C Infection | Phase 1 | Status: TERMINATED